01 1Allastir
02 1Anthem Biosciences
03 1F. Hoffmann-La Roche
04 1Hoventa Pharma
05 1Recordati
06 1SIGMA TAU
07 2Sekisui Medical Co. Ltd
08 1Wuxi Further Pharmaceutical Co Ltd
01 1China
02 3India
03 1Italy
04 2Japan
05 1Switzerland
06 1U.S.A
01 1Active
02 2Inactive
03 6Blank
01 9Blank
01 1217MF10780
02 1227MF10188
03 7Blank
01 9Blank
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14942
Submission : 2000-06-26
Status : Active
Type : II
NDC Package Code : 12711-7490
Start Marketing Date : 1993-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2162
Submission : 1973-10-04
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5213
Submission : 1983-06-15
Status : Inactive
Type : II
Registration Number : 217MF10780
Registrant's Address : 2-1-3 Nihonbashi, Chuo-ku, Tokyo
Initial Date of Registration : 2005-10-20
Latest Date of Registration : --
Registration Number : 227MF10188
Registrant's Address : 2-1-3 Nihonbashi, Chuo-ku, Tokyo
Initial Date of Registration : 2015-08-03
Latest Date of Registration : --
We have 8 companies offering Pyridoxal phosphate anhydrous
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
